Sage Journals: Discover world-class research

Abstract

French

Four prototype patient package inserts (PPIs) for erythromycin were tested in an analog study using 325 individuals drawn from a college community. There was no difference in the total amount of knowledge communicated by the different PPIs, but results for individual test items suggest (1) that more explicit information may be better recalled, and (2) that longer PPIs may aid in information integration, whereas shorter PPIs may aid in pure recall of facts. PPIs containing elaboration on why drug effects occur were rated by the subjects as more “accurate.” Subjects tended to rate PPIs that provided behavioral instructions on what to do if certain drug effects occurred as designed to promote better care.

Get full access to this article

View all access options for this article.

References

Myers

Patient package inserts: content and format. Rockville, MD: Food and Drug Administration, 1979. (FDA no. 79–3089).

Jacoby

Chestnut

Silberman

Consumer use and comprehension of nutrition information. J Consumer Res 1977; 4 (Sept.): 119–28.

Jacoby

Information load and decision quality: some contested issues. J Marketing Res 1977; 14: 569–73.

Joubert

Lasagna

Patient package inserts II. Toward a rational patient package insert. Clin Pharmacol Ther 1975; 18: 663–9.

Morris

Mazis

Gordon

A survey of the effects of oral contraceptive patient information. JAMA 1977; 238: 2504–8.

Scammon

DL.

“Information load” and consumers. J Consumer Res 1977; 4 (Dec.): 148–55.

Jonsen

Medical ethicist perspective. In: Myers

ed. Patient package inserts: content and format. Rockville, MD: Food and Drug Administration, 1979. FDA no. 79–3089: 21–7.

Ley

Towards better doctor-patient communications. In: Bennett

ed. Communications between doctors and patients. London: Oxford University Press, 1976: 77–98.

Hermann

Herxheimer

Lionel

NDW.

Package inserts for prescribed medicine: what minimum information do patients need? Br Med J 1978; 2: 1132–5.

10.

Dwyer

Hammel

An experimental study: patient package inserts and their effects on hypertensive patients. Urban Health 1978; 7 (June): 46–7, 56, 59–60.

11.

Morris

Thilman

Guerin

Consumer reactions to four prototype patient package inserts for erythromycin: a focus group analysis. Rockville, MD: Food and Drug Administration, and Bethesda, MD: Uniworld Group, 1979. National Technical Information Service, Springfield, VA: PB- 296–361AS, (March), 1979.

Consumer Reactions to Differing Amounts of Written Drug Information

Abstract

Get full access to this article

References